MODULATION OF THE NEUROFIBROMATOSIS TYPE-1 GENE-PRODUCT, NEUROFIBROMIN, DURING SCHWANN-CELL DIFFERENTIATION

被引:57
作者
GUTMANN, DH
TENNEKOON, GI
COLE, JL
COLLINS, FS
RUTKOWSKI, JL
机构
[1] UNIV MICHIGAN, MED CTR, DEPT NEUROL, ANN ARBOR, MI 48109 USA
[2] UNIV MICHIGAN, MED CTR, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA
[3] UNIV MICHIGAN, MED CTR, DEPT PEDIAT, ANN ARBOR, MI 48109 USA
[4] UNIV MICHIGAN, MED CTR, DEPT INTERNAL MED, ANN ARBOR, MI 48109 USA
关键词
NF1; GTPASE-ACTIVATING PROTEIN; P21-RAS; CAMP;
D O I
10.1002/jnr.490360212
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurofibromin, the product of the neurofibromatosis type 1 (NF1) gene, is a approximately 250 kDa protein expressed predominantly in cortical neurons and oligodendrocytes in the central nervous system (CNS) and sensory neurons and Schwann cells in the peripheral nervous system (PNS). To gain insight into the biological role of neurofibromin in Schwann cells, the modulation of NF1 gene expression in a Schwann cell line (MT4H1) stimulated to either proliferate or differentiate in response to agents that elevate intracellular cAMP was examined. Untreated cells and cells exposed to mitogenic doses of forskolin (1-10 muM) or 8-bromo-cAMP (0.1 mM) expressed low levels of NF1 mRNA and the protein was barely detectable. High doses of forskolin (100 muM) or 8-bromo-cAMP (1 mM) induced the expression of both myelin P0 protein and neurofibromin with an identical time course. Although NF1 mRNA levels peaked within 1-6 hr, the rise in neurofibromin was not apparent until 24-48 hr and peaked 72 hr after treatment. P0 and neurofibromin were also coinduced by cell-cell contact in high density, untreated cultures. Moreover, differentiation initiated by either cAMP stimulation or high density culture conditions was associated with predominant expression of the type 2 NF1 mRNA isoform. In contrast, type I NF1 mRNA isoform expression was observed in untreated Schwann cells or those stimulated with mitogenic doses of forskolin or 8-bromo-cAMP. A switch from the type 1 neurofibromin that can efficiently down-regulate p21-ras to the type 2 isoform with reduced activity may facilitate a p21-ras signaling pathway associated with Schwann cell differentiation. (C) 1993 Wiley-Liss, Inc.
引用
收藏
页码:216 / 223
页数:8
相关论文
共 36 条
  • [1] A CONSERVED ALTERNATIVE SPLICE IN THE VONRECKLINGHAUSEN NEUROFIBROMATOSIS (NF1) GENE PRODUCES 2 NEUROFIBROMIN ISOFORMS, BOTH OF WHICH HAVE GTPASE-ACTIVATING PROTEIN-ACTIVITY
    ANDERSEN, LB
    BALLESTER, R
    MARCHUK, DA
    CHANG, E
    GUTMANN, DH
    SAULINO, AM
    CAMONIS, J
    WIGLER, M
    COLLINS, FS
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) : 487 - 495
  • [2] NEUROFIBROMATOSIS AND CANCER
    BADER, JL
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 486 : 57 - 65
  • [3] THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS
    BALLESTER, R
    MARCHUK, D
    BOGUSKI, M
    SAULINO, A
    LETCHER, R
    WIGLER, M
    COLLINS, F
    [J]. CELL, 1990, 63 (04) : 851 - 859
  • [4] MICROINJECTION OF THE RAS ONCOGENE PROTEIN INTO PC12 CELLS INDUCES MORPHOLOGICAL-DIFFERENTIATION
    BARSAGI, D
    FERAMISCO, JR
    [J]. CELL, 1985, 42 (03) : 841 - 848
  • [5] ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS
    BASU, TN
    GUTMANN, DH
    FLETCHER, JA
    GLOVER, TW
    COLLINS, FS
    DOWNWARD, J
    [J]. NATURE, 1992, 356 (6371) : 713 - 715
  • [6] CHARACTERIZATION OF FULL-LENGTH NEUROFIBROMIN - TUBULIN INHIBITS RAS GAP ACTIVITY
    BOLLAG, G
    MCCORMICK, F
    CLARK, R
    [J]. EMBO JOURNAL, 1993, 12 (05) : 1923 - 1927
  • [7] A MAJOR SEGMENT OF THE NEUROFIBROMATOSIS TYPE-1 GENE - CDNA SEQUENCE, GENOMIC STRUCTURE, AND POINT MUTATIONS
    CAWTHON, RM
    WEISS, R
    XU, GF
    VISKOCHIL, D
    CULVER, M
    STEVENS, J
    ROBERTSON, M
    DUNN, D
    GESTELAND, R
    OCONNELL, P
    WHITE, R
    [J]. CELL, 1990, 62 (01) : 193 - 201
  • [8] THE PROTEIN PRODUCT OF THE NEUROFIBROMATOSIS TYPE-1 GENE IS EXPRESSED AT HIGHEST ABUNDANCE IN NEURONS, SCHWANN-CELLS, AND OLIGODENDROCYTES
    DASTON, MM
    SCRABLE, H
    NORDLUND, M
    STURBAUM, AK
    NISSEN, LM
    RATNER, N
    [J]. NEURON, 1992, 8 (03) : 415 - 428
  • [9] ABNORMAL REGULATION OF MAMMALIAN P21(RAS) CONTRIBUTES TO MALIGNANT-TUMOR GROWTH IN VONRECKLINGHAUSEN (TYPE-1) NEUROFIBROMATOSIS
    DECLUE, JE
    PAPAGEORGE, AG
    FLETCHER, JA
    DIEHL, SR
    RATNER, N
    VASS, WC
    LOWY, DR
    [J]. CELL, 1992, 69 (02) : 265 - 273
  • [10] IDENTIFICATION AND CHARACTERIZATION OF THE NEUROFIBROMATOSIS TYPE-1 PROTEIN PRODUCT
    DECLUE, JE
    COHEN, BD
    LOWY, DR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) : 9914 - 9918